Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
First line chemotherapy of metastatic breast cancerP Pronzato, M Rondini
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Hormonotherapy of advanced prostate cancerP Pronzato, M Rondini
Annals of the New York Academy of Sciences|November 30, 1993
A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancerP Pronzato, G Bertelli, M Rosso
Archivio "E. Maragliano" Di Patologia E Clinica|January 1, 1978
[Role of gastrin in function of the entero-insular axis]N Elicio, G Chiodini, P Pronzato, et al.
Anticancer Research|July 1, 1988
Idarubicin: an evaluation of cardiac toxicity in 77 patients with solid tumorsG Bertelli, D Amoroso, P Pronzato, et al.
Tumori|January 31, 1998
[Low-dose GM-CSF and dose intensity of antineoplastic agents]P Pronzato, F Pensa, F Vaira, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot studyP Pronzato, P Losardo, F Pensa, et al.
British Journal of Cancer|June 1, 1996
A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancerP Pronzato, G Bertelli, A Vigani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
What do advanced cancer patients know of their disease? A report from ItalyP Pronzato, G Bertelli, P Losardo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1984
Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patientsA Ardizzoni, P Pronzato, P F Conte, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
First line chemotherapy of metastatic breast cancerP Pronzato, M Rondini
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Hormonotherapy of advanced prostate cancerP Pronzato, M Rondini
Annals of the New York Academy of Sciences|November 30, 1993
A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancerP Pronzato, G Bertelli, M Rosso
Archivio "E. Maragliano" Di Patologia E Clinica|January 1, 1978
[Role of gastrin in function of the entero-insular axis]N Elicio, G Chiodini, P Pronzato, et al.
Anticancer Research|July 1, 1988
Idarubicin: an evaluation of cardiac toxicity in 77 patients with solid tumorsG Bertelli, D Amoroso, P Pronzato, et al.
Tumori|January 31, 1998
[Low-dose GM-CSF and dose intensity of antineoplastic agents]P Pronzato, F Pensa, F Vaira, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot studyP Pronzato, P Losardo, F Pensa, et al.
British Journal of Cancer|June 1, 1996
A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancerP Pronzato, G Bertelli, A Vigani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
What do advanced cancer patients know of their disease? A report from ItalyP Pronzato, G Bertelli, P Losardo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1984
Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patientsA Ardizzoni, P Pronzato, P F Conte, et al.
Pageof 13